Editorial: Statins and Liver Disease: Is it Time to Recommend Statins to Prevent Liver Disease Progression?

about

Editorial: Statins and Liver Disease: Is it Time to Recommend Statins to Prevent Liver Disease Progression?

Item

http://www.wikidata.org/entity/Q46131886

description

2017 nî lūn-bûn

@nan

2017 թվականի հոկտեմբերին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

name

Editorial: Statins and Liver D ...... ent Liver Disease Progression?

@en

Editorial: Statins and Liver D ...... ent Liver Disease Progression?

@nl

type

Item

label

Editorial: Statins and Liver D ...... ent Liver Disease Progression?

@en

Editorial: Statins and Liver D ...... ent Liver Disease Progression?

@nl

prefLabel

Editorial: Statins and Liver D ...... ent Liver Disease Progression?

@en

Editorial: Statins and Liver D ...... ent Liver Disease Progression?

@nl

P1476

Editorial: Statins and Liver D ...... ent Liver Disease Progression?

@en

P2093

Jennifer C Price

http://www.w3.org/2001/XMLSchema#string

Phyllis C Tien

http://www.w3.org/2001/XMLSchema#string

P2860

Statins for Prevention of Cardiovascular Disease in Adults: Evidence Report and Systematic Review for the US Preventive Services Task Force.

Spectrum of statin hepatotoxicity: experience of the drug-induced liver injury network

An assessment by the Statin Liver Safety Task Force: 2014 update.

Narrative review: statin-related myopathy.

Statins are associated with a reduced risk of hepatocellular cancer: a systematic review and meta-analysis.

Rationale for the use of statins in liver disease.

Addition of Simvastatin to Standard Therapy for the Prevention of Variceal Rebleeding Does Not Reduce Rebleeding but Increases Survival in Patients With Cirrhosis.

Hepatotoxicity fears contribute to underutilization of statin medications by primary care physicians.

Hepatic effects of lovastatin exposure in patients with liver disease: a retrospective cohort study.

Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial.

P304

1506-1507

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1038/AJG.2017.250

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

112

http://www.w3.org/2001/XMLSchema#string

P577

2017-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28978973

http://www.w3.org/2001/XMLSchema#string